CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,275 | -72.3% | 119 | -65.9% | 0.00% | – |
| Q2 2023 | $11,842 | -18.9% | 349 | -14.0% | 0.00% | – |
| Q1 2023 | $14,608 | -19.3% | 406 | 0.0% | 0.00% | – |
| Q4 2022 | $18,095 | +64.5% | 406 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | 0.0% | 406 | 0.0% | 0.00% | – |
| Q2 2022 | $11,000 | -21.4% | 406 | 0.0% | 0.00% | – |
| Q1 2022 | $14,000 | -12.5% | 406 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -27.3% | 406 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | +57.1% | 406 | 0.0% | 0.00% | – |
| Q2 2021 | $14,000 | +75.0% | 406 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | +33.3% | 406 | +14.0% | 0.00% | – |
| Q4 2020 | $6,000 | – | 356 | +5833.3% | 0.00% | – |
| Q2 2020 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |